July 26, 2016

Society for Women’s Health Research Launches New Interdisciplinary Network to Focus on Sex Differences in Alzheimer’s Disease

Leading researchers, scientists, and clinicians to examine sex differences in Alzheimer’s disease with a focus on Women

The Society for Women’s Health Research (SWHR), the leading voice in research on biological differences between women and men, announces the start of a new initiative focused on examining sex and gender differences in Alzheimer’s disease.

“SWHR is proud to assemble some of the best researchers in the country to examine sex differences in Alzheimer’s disease and promote policies to advance Alzheimer’s disease research. The focus on sex differences is needed to understand why the risk for Alzheimer’s disease and its progression are different in women compared to men, and to further improve our current efforts for better therapies and prevention strategies,“ said Monica Mallampalli, PhD, MSc., SWHR Vice President of Scientific Affairs.

The members of the SWHR Interdisciplinary Network on Alzheimer’s Disease will work collaboratively over the next five years to address areas of need in Alzheimer’s disease pertaining to both research and policy.

“This unique Network addresses aging and dementia, one of the most important issues facing modern societies and it does so in the context of sex differences and how they are manifested across the life course,” said Bruce McEwen, PhD, Alfred E. Mirsky Professor of Neuroscience at the Rockefeller University, Director of the Harold and Margaret Milliken Hatch Laboratory of Neuroendocrinology, member of the SWHR Board of Directors and now current member of SWHR Interdisciplinary Network on Alzheimer’s Disease. “This Network fills an important gap, as no other group is likely to do this.”

The Network officially launched following a successful introductory meeting held by SWHR on July 20, 2016. The highlights of the meeting included a review of each member’s research expertise, a discussion of Network members’ viewpoints on Alzheimer’s disease, and their thoughts on prevention and treatment, latest research advances, and evidence-based policy needs.

Click here to learn more about the Network.